Medicis Pharmaceutical Corp. (MRX) Tops Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $70.54 -3.36%
Financial Fact:
Other (income) expense, net: 7.74M
Today's EPS Names:
VIPS, QFIN, STRT, More
Financial Fact:
Other (income) expense, net: 7.74M
Today's EPS Names:
VIPS, QFIN, STRT, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q1 EPS of $0.91, $0.14 better than the analyst estimate of $0.77. Revenue for the quarter came in at $467.3 million versus the consensus estimate of $428.46 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Starts JBT Marel Corp. (JBTM) at Overweight
- Goldman Sachs Downgrades Daqo New Energy (DQ) to Sell
- Bernstein SocGen Group Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
